Zhejiang Yatai Pharmaceutical Co Ltd Total Liabilities
Zhejiang Yatai Pharmaceutical Co Ltd total liabilities. Based on the latest financial reports, Zhejiang Yatai Pharmaceutical Co Ltd (002370) has total liabilities worth CN¥115.18 Million CNY (≈ $16.86 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check how resilient are Zhejiang Yatai Pharmaceutical Co Ltd's assets to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Zhejiang Yatai Pharmaceutical Co Ltd (2006–2025)
Total liabilities of Zhejiang Yatai Pharmaceutical Co Ltd from 2006 to 2025. This chart illustrates how Zhejiang Yatai Pharmaceutical Co Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore Zhejiang Yatai Pharmaceutical Co Ltd strategic investment ratio to see how much of total assets are deployed in long-term investments.
Zhejiang Yatai Pharmaceutical Co Ltd Competitors by Total Liabilities
The table below lists competitors of Zhejiang Yatai Pharmaceutical Co Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Figeac Aero SA
PA:FGA
|
France | €619.70 Million |
|
Caleres Inc
NYSE:CAL
|
USA | $1.40 Billion |
|
EQV Ventures Acquisition Corp. II
NYSE:EVAC
|
USA | $490.72 Million |
|
MiCo Ltd
KQ:059090
|
Korea | ₩1.12 Trillion |
|
Foseco India Limited
NSE:FOSECOIND
|
India | Rs-11.20 Billion |
|
Ruitai Materials Technology Co Ltd
SHE:002066
|
China | CN¥3.60 Billion |
|
Bank Mestika Dharma Tbk
JK:BBMD
|
Indonesia | Rp11.23 Trillion |
|
Juniper Hotels Ltd
NSE:JUNIPER
|
India | Rs16.14 Billion |
Liability Composition Analysis (2006–2025)
This chart breaks down Zhejiang Yatai Pharmaceutical Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see total assets of Zhejiang Yatai Pharmaceutical Co Ltd.
Liquidity & Leverage Metrics
Zhejiang Yatai Pharmaceutical Co Ltd Total Liabilities Ratios Explained
Zhejiang Yatai Pharmaceutical Co Ltd total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 7.91 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.10 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.09 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Zhejiang Yatai Pharmaceutical Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Zhejiang Yatai Pharmaceutical Co Ltd (2006–2025)
The table below shows the annual total liabilities of Zhejiang Yatai Pharmaceutical Co Ltd from 2006 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | CN¥159.43 Million ≈ $23.33 Million |
-62.89% |
| 2024-12-31 | CN¥429.59 Million ≈ $62.86 Million |
-49.37% |
| 2023-12-31 | CN¥848.50 Million ≈ $124.16 Million |
-30.59% |
| 2022-12-31 | CN¥1.22 Billion ≈ $178.88 Million |
+3.79% |
| 2021-12-31 | CN¥1.18 Billion ≈ $172.35 Million |
-9.11% |
| 2020-12-31 | CN¥1.30 Billion ≈ $189.63 Million |
-20.75% |
| 2019-12-31 | CN¥1.64 Billion ≈ $239.29 Million |
+40.68% |
| 2018-12-31 | CN¥1.16 Billion ≈ $170.10 Million |
+104.07% |
| 2017-12-31 | CN¥569.62 Million ≈ $83.35 Million |
+114.39% |
| 2016-12-31 | CN¥265.69 Million ≈ $38.88 Million |
-79.04% |
| 2015-12-31 | CN¥1.27 Billion ≈ $185.52 Million |
+1152.60% |
| 2014-12-31 | CN¥101.21 Million ≈ $14.81 Million |
+9.97% |
| 2013-12-31 | CN¥92.04 Million ≈ $13.47 Million |
-19.32% |
| 2012-12-31 | CN¥114.08 Million ≈ $16.69 Million |
-9.81% |
| 2011-12-31 | CN¥126.48 Million ≈ $18.51 Million |
-12.78% |
| 2010-12-31 | CN¥145.02 Million ≈ $21.22 Million |
-31.62% |
| 2009-12-31 | CN¥212.08 Million ≈ $31.03 Million |
+0.59% |
| 2008-12-31 | CN¥210.84 Million ≈ $30.85 Million |
+3.10% |
| 2007-12-31 | CN¥204.51 Million ≈ $29.93 Million |
+15.44% |
| 2006-12-31 | CN¥177.15 Million ≈ $25.92 Million |
-- |
About Zhejiang Yatai Pharmaceutical Co Ltd
Zhejiang Yatai Pharmaceutical Co., Ltd. researches, produces, sells, and exports pharmaceutical products in China and internationally. The company offers solid dosage, cephalosporin powder injection, and freeze-dried powder injection products. It also provides various antibiotic and non-antibiotic drugs. The company was founded in 1989 and is based in Shaoxing, China.